An increase in IL-6 levels at 6-month follow-up visit is associated with SSRI-emergent suicidality in high-risk children and adolescents treated with fluoxetine
Neurobiology of suicide in times of social isolation and loneliness
Neuropeptide Y plasma levels and suicidal behavior in combat veterans